Technical Analysis for PYPD - PolyPid Ltd.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | -2.95% | |
| MACD Bullish Signal Line Cross | Bullish | -2.95% | |
| Gapped Up | Strength | -2.95% | |
| Fell Below 20 DMA | Bearish | 5.67% | |
| MACD Bearish Signal Line Cross | Bearish | 5.67% | |
| Calm After Storm | Range Contraction | 5.67% | |
| Narrow Range Bar | Range Contraction | 5.67% | |
| Gapped Down | Weakness | 5.67% | |
| 20 DMA Support | Bullish | -3.01% | |
| Gapped Down | Weakness | -3.01% |
| Alert | Time |
|---|---|
| 2x Volume Pace | about 3 hours ago |
| 1.5x Volume Pace | about 3 hours ago |
| 3x Volume Pace | about 3 hours ago |
| Down 5% | about 3 hours ago |
| Down 3% | about 3 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform. Its products include D-PLEX, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX100 for the prevention of post-abdominal surgery incisional infection; BONYPID-1000, an antibiotic eluting ß tri-calcium phosphate granule for bone related infections applications; and BONYPID500, an antibiotic eluting bone graft substitute that fills and reconstructs periodontal and oral/maxillofacial defects, while protecting from infections. PolyPid Ltd. was founded in 2008 and is headquartered in Petach Tikva, Israel.
Sector: Healthcare
Industry: Biotechnology
Keywords: Surgery Bone Infection Phosphates Antibiotics Lipid Polyp Incision Bone Grafting Surgical Site
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Surgery Bone Infection Phosphates Antibiotics Lipid Polyp Incision Bone Grafting Surgical Site
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.2 |
| 52 Week Low | 3.601 |
| Average Volume | 2,440 |
| 200-Day Moving Average | 5.83 |
| 50-Day Moving Average | 4.80 |
| 20-Day Moving Average | 4.66 |
| 10-Day Moving Average | 4.69 |
| Average True Range | 0.25 |
| RSI (14) | 50.74 |
| ADX | 15.76 |
| +DI | 28.21 |
| -DI | 30.72 |
| Chandelier Exit (Long, 3 ATRs) | 4.33 |
| Chandelier Exit (Short, 3 ATRs) | 4.96 |
| Upper Bollinger Bands | 5.09 |
| Lower Bollinger Band | 4.23 |
| Percent B (%b) | 0.59 |
| BandWidth | 18.64 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.05 |
| MACD Histogram | 0.0024 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.99 | ||||
| Resistance 3 (R3) | 4.96 | 4.85 | 4.95 | ||
| Resistance 2 (R2) | 4.85 | 4.79 | 4.86 | 4.93 | |
| Resistance 1 (R1) | 4.80 | 4.75 | 4.82 | 4.82 | 4.92 |
| Pivot Point | 4.69 | 4.69 | 4.70 | 4.70 | 4.69 |
| Support 1 (S1) | 4.63 | 4.62 | 4.66 | 4.66 | 4.56 |
| Support 2 (S2) | 4.52 | 4.58 | 4.53 | 4.55 | |
| Support 3 (S3) | 4.47 | 4.52 | 4.53 | ||
| Support 4 (S4) | 4.49 |
